arrow
Return

Complement inhibition can decrease the haemostatic response in a microvascular bleeding model at multiple levels

delete2023-09-13
delete3
delete
OA
AI
M
Murielle Golomingi
J
Jessie Kohler
C
Christina Lamers
R
Richard B. Pouw
D
Daniel Ricklin
J
József Dobó
P
Péter Gál
G
Gábor Pál
B
Bence Kiss
A
Arthur Dopler
C
Christoph Q. Schmidt
E
Elaissa T. Hardy
W
Wilbur A. Lam
V
Verena Schroeder *
DOI:10.3389/fimmu.2023.1226832delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
BackgroundHaemostasis is a crucial process by which the body stops bleeding. It is achieved by the formation of a platelet plug, which is strengthened by formation of a fibrin mesh mediated by the coagulation cascade. In proinflammatory and prothrombotic conditions, multiple interactions of the complement system and the coagulation cascade are known to aggravate thromboinflammatory processes and increase the risk of arterial and venous thrombosis. Whether those interactions also play a relevant role during the physiological process of haemostasis is not yet completely understood. The aim of this study was to investigate the potential role of complement components and activation during the haemostatic response to mechanical vessel injury.MethodsWe used a microvascular bleeding model that simulates a blood vessel, featuring human endothelial cells, perfusion with fresh human whole blood, and an inducible mechanical injury to the vessel. We studied the effects of complement inhibitors against components of the lectin (MASP-1, MASP-2), classical (C1s), alternative (FD) and common pathways (C3, C5), as well as a novel triple fusion inhibitor of all three complement pathways (TriFu). Effects on clot formation were analysed by recording of fibrin deposition and the platelet activation marker CD62P at the injury site in real time using a confocal microscope.ResultsWith the inhibitors targeting MASP-2 or C1s, no significant reduction of fibrin formation was observed, while platelet activation was significantly reduced in the presence of the FD inhibitor. Both common pathway inhibitors targeting C3 or C5, respectively, were associated with a substantial reduction of fibrin formation, and platelet activation was also reduced in the presence of the C3 inhibitor. Triple inhibition of all three activation pathways at the C3-convertase level by TriFu reduced both fibrin formation and platelet activation. When several complement inhibitors were directly compared in two individual donors, TriFu and the inhibitors of MASP-1 and C3 had the strongest effects on clot formation.ConclusionThe observed impact of complement inhibition on reducing fibrin clot formation and platelet activation suggests a role of the complement system in haemostasis, with modulators of complement initiation, amplification or effector functions showing distinct profiles. While the interactions between complement and coagulation might have evolved to support haemostasis and protect against bleeding in case of vessel injury, they can turn harmful in pathological conditions when aggravating thromboinflammation and promoting thrombosis.
Keywords:
haemostasis
complement system
MBL-associated serine protease-2 (MASP-2)
complement C1s
complement factor D (FD)
complement C3
complement C5
microfluidics

Journal

Frontiers in Immunology cover
Frontiers in Immunology
IF:
5.9
Papers:
5.3W
Citations:
29.8W

Organization

H
Hun-Ren Research Centre for Natural Sciences
Scholars:
75
Papers: 26
Citations: 1.3K
U
University of Bern
Scholars:
2.0K
Papers: 771
Citations: 2.2W
H
HUN-REN
Scholars:
5
Papers: 1
Citations: 3.5K
U
university of basel
Scholars:
1.5K
Papers: 540
Citations: 1.9W
E
eotvos-lorand university
Scholars:
2
Papers: 1
Citations: 0
I
institute of enzymology - has
Scholars:
206
Papers: 146
Citations: 130
researcher View more organizations
Cited Papers

Cited Papers

ADP and AMP Induce Interleukin-1β Release from Microglial Cells through Activation of ATP-Primed P2X7 Receptor Channels
err2002-04-15
err0
errOAAI
errYassar Chakfe; Rosanne Seguin; Jack P. Antel; Céline Morissette; Danielle Malo; Duncan Henderson; Philippe Séguéla
errShare
errSave
Complement in autoimmune diseases
err2017-02-01
err105
PREAI
errVignesh, Pandiarajan; Rawat, Amit; Sharma, Madhubala; Singh, Surjit
errShare
errSave
Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration
err2017-06-21
err145
errOAAI
errYaspan, Brian L.; Williams, David F.; Holz, Frank G.; Regillo, Carl D.; Li, Zhengrong; Dressen, Amy; Campagne, Menno van Lookeren; Le, Kha N.; Graham, Robert R.; Beres, Tatiana; Bhangale, Tushar R.; Honigberg, Lee A.; Smith, Ashley; Henry, Erin C.; Ho, Carole; Strauss, Erich C.
errShare
errSave
Increased risk of thrombotic events in cold agglutinin disease: A 10-year retrospective analysis
err2020-05-01
err59
errOAAI
errBroome, Catherine M.; Cunningham, Julia M.; Mullins, Megan; Jiang, Xiaohui; Bylsma, Lauren C.; Fryzek, Jon P.; Rosenthal, Adam
errShare
errSave
researcher View more